USPatent applicationPatented

Astringent shave preparations

Granted 12 Oct 2004 · 2 office actions

Current assignee: Cognis IP Management GmbH · originally Cognis Corporation

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Pat Hoontrakul, James A. McCaulley · Examiner: James M. Spear · AU 1615 · TC 1600

Life of the application

13 dated events
⤢ drag to zoom200020022004200620082010201220142016201820202022ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

A shaving composition containing a skin-tightening effective amount of an astringent additive, wherein the shaving composition is applied onto human skin prior to shaving.

Description

9 parts
›CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of copending provisional application serial No. 60/246,355 filed on Nov. 7, 2000.

›STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT

Not applicable.

›BACKGROUND OF THE INVENTION

The present invention generally relates to shaving preparations which are applied onto a person's skin prior to shaving. A common problem associated with the act of shaving is the formation of razor bumps on the shaved surface, i.e., pseudofolliculitis barbae (PFB). This is a shaving-induced condition caused by re-entrant penetration of newly-cut hairs into the skin resulting in significant skin irritation.

Hairs which lie nearly parallel to the skin have a tendency of being cut at an acute angle, producing sharp points that can penetrate into the skin. Those individuals whose hair follicles have a strong natural curl are even more susceptible to this type of skin condition. The re-entrant hair induces an antigenic, foreign body reaction, leading to the formation of papules or cysts that appear as raised bumps on the skin's surface. These raised bumps are further irritated by subsequent acts of shaving. The local irritation may be further worsened by bacterial infection, as is oftentimes the case with acne.

Efforts have been made to prevent and/or inhibit PFB from occurring. These efforts, however, have focused on preventing the initial re-entrant penetration of newly shaved hairs using chemical compounds commonly employed in the treatment of acne such as, for example, benzoyl peroxide, acetylsalicylic acid, and the like.

›BRIEF SUMMARY OF THE INVENTION

The present invention is directed to a shaving composition containing a skin-tightening effective amount of an astringent compound, wherein the shaving composition is applied onto human skin prior to shaving.

The present invention is also directed to a process for inhibiting re-entrant penetration of newly shaved hair into human skin involving:

(a) providing a shaving composition containing a skin-tightening effective amount of an astringent compound; and

(b) applying the shaving composition onto human skin prior to shaving.

›DETAILED DESCRIPTION OF THE INVENTION

Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients and/or reaction conditions, are to be understood as being modified in all instances by the term “about”.

It has surprisingly been discovered that by applying a shaving composition containing an astringent compound onto human skin prior to shaving, the re-entrant penetration of newly shaved hairs back into the skin can be effectively inhibited. The shaving composition of the present invention also provides for a closer shave because the astringent contained in the shaving composition causes the skin to tighten, thereby enabling a much smoother shave. Moreover, application of this composition prior to shaving also causes the hair follicles to lie more upright, which also facilitates a closer shave and causes the shaved hairs to have blunt rather than sharp ends.

While any suitable astringent compound may be employed such as, for example, witch hazel extract or zinc paraphenolsulfonate, a particularly effective astringent additive is a mixture of butylene glycol and Fomes Officinalis (mushroom extract) commercially available from Laboratories Serobiologiques under the tradename LARICYL® LS 8865.

The astringent compound may be employed in any conventional type of shaving composition. A particularly preferred shaving composition is a shaving gel. This type of composition is typically in the form of an oil-in-water emulsion containing water and a water-soluble soap component and/or synthetic wetting agent.

The primary component of the shaving gel is water, preferably deionized or distilled water. The soap component is typically a water soluble salt of a fatty acid. Examples thereof include, but are not limited to, triethanolamine soaps of stearic and palmitic acids, animal-derived soaps, vegetable-derived soaps, and mixtures thereof. Synthetic wetting agents, when used, are typically of the nonionic variety. Examples thereof include, but are not limited to, water-soluble alkoxylated fatty alcohols, water soluble polyoxyethylene ethers of alkyl-substituted phenols, and the like.

The shaving gel may also include a self-foaming agent, if desired, which provides for the formation of foam when spread over a person's skin and beard. Typically, a low boiling aliphatic hydrocarbon is used as the volatile self-foaming agent. Examples thereof include, but are not limited to, n-pentane, isopentane, neopentane, n-butane, isobutane, and mixtures thereof.

According to one aspect of the present invention, there is provided a shaving composition containing an astringent additive for use prior to shaving. The astringent additive may be present in the shaving composition in an amount of from about 0.1 to about 35% by weight, preferably from about 1 to about 20% by weight, and most preferably from about 2 to about 10% by weight, all weights being based on the weight of the composition.

According to another aspect of the present invention, there is provided a process for inhibiting the re-entrant penetration of newly shaved hair into human skin. The process involves contacting the area to be shaved, prior to shaving, with the above-described shaving composition.

The present invention will be better understood by the following examples, all of which are intended to be illustrative only, and are not meant to unduly limit the scope of the invention.

EXAMPLES
›Examples3
›Example 1

A non-foaming shaving gel was prepared per the following formulation.

The non-foaming shaving gel was applied onto human skin, prior to shaving, producing a strong tingling/tightening sensation during the contact time required for shaving.

›Example 2

A foaming shave gel was prepared per the following formulation.

›Example 3

A foaming shave gel was prepared per the following formulation.

›Tables in the description — 3
Component% by weight
water91.04
ELESTAB ® 3382.50
hydroxyethyl cellulose0.50
CARBOMER ®0.16
sodium hydroxide (1N)0.80
LARICYL ® LS 88655.00
Component% by weight
water37.10
ELESTAB ® 3381.00
hydroxypropyl methylcellulose0.60
triethanolamine (99%)0.30
cocamide MEA5.50
citric acid (50%)0.30
ammonium lauryl sulfate28.00
ammonium laureth sulfate21.00
dimethicone copolyol0.20
lauryl glycoside2.00
cocoglycoside + glycerol oleate1.00
LARICYL ® LS 88653.00
Component% by weight
water35.80
ELESTAB ® 3381.00
hydroxypropyl methylcellulose0.50
triethanolamine (99%)0.30
cocamide MEA6.00
ammonium lauryl sulfate28.00
ammonium laureth sulfate23.00
dimethicone copolyol0.20
cocamidopropylamine oxide2.00
LARICYL ® LS 88653.00

Claims as granted

12 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

8 codes
IPC · International Patent Classification
Section A — Human necessities
  • A61K8/04
  • A61Q9/02
  • A61K8/97
  • A61K8/37
  • A61K8/34
  • A61K8/36
USPC · US Patent Classification
424/73514/848

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomJan 2002Jul 2002Jan 2003Jul 2003Jan 2004Jul 2004USPTOApplicantNon-final rejectionResponse after non-finalResponse after non-finalNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
2.9 y
1,070 days filing → grant
Office actions
2
non-final + final
Responses
2
no RCE
Examiner
James M. Spear
art unit 1615 · TC 1600
Citations: 8 back · 3 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom20022004200620082010201220142016201820202022Owner 1Owner 2Owner 3
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock